Keros Therapeutics, Inc.
KROS
Revenue
243.86M
▲229.74M▲1626.59%
3 Months ChangeAssets
338.02M
▼-404.76M▼-54.49%
3 Months ChangeLiabilities
34.89M
▼-4.31M▼-11.00%
3 Months ChangeFree Cash Flow
160.61M
▲206.11M▲452.93%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-09
Form 8-K
ID: 0001664710-26-000024
2026-03-04
Form 8-K
ID: 0001664710-26-000021
2026-03-04
Form 8-K
ID: 0001664710-26-000017
2026-02-26
Form 8-K
ID: 0001664710-26-000008
2026-02-18
Form 8-K
ID: 0001664710-26-000005
2026-01-09
Form 8-K
ID: 0001664710-26-000003
2025-11-05
Form 10-Q
ID: 0001664710-25-000089
2025-11-05
Form 8-K
ID: 0001664710-25-000086
2025-10-15
Form 8-K
ID: 0001104659-25-099512
2025-09-08
Form 8-K
ID: 0001664710-25-000081